DK0552280T3 - Inhibering af viral replikation - Google Patents

Inhibering af viral replikation

Info

Publication number
DK0552280T3
DK0552280T3 DK91919581.8T DK91919581T DK0552280T3 DK 0552280 T3 DK0552280 T3 DK 0552280T3 DK 91919581 T DK91919581 T DK 91919581T DK 0552280 T3 DK0552280 T3 DK 0552280T3
Authority
DK
Denmark
Prior art keywords
inhibition
viral replication
dna
cell
viral
Prior art date
Application number
DK91919581.8T
Other languages
English (en)
Inventor
Michael J Scolaro
Sean M Sullivan
Original Assignee
Nexstar Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nexstar Pharmaceuticals Inc filed Critical Nexstar Pharmaceuticals Inc
Application granted granted Critical
Publication of DK0552280T3 publication Critical patent/DK0552280T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C12N15/1131—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against viruses
    • C12N15/1132—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against viruses against retroviridae, e.g. HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
DK91919581.8T 1990-10-09 1991-10-09 Inhibering af viral replikation DK0552280T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US59525390A 1990-10-09 1990-10-09

Publications (1)

Publication Number Publication Date
DK0552280T3 true DK0552280T3 (da) 1995-08-28

Family

ID=24382446

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91919581.8T DK0552280T3 (da) 1990-10-09 1991-10-09 Inhibering af viral replikation

Country Status (9)

Country Link
EP (1) EP0552280B1 (da)
JP (1) JPH06504429A (da)
AT (1) ATE124457T1 (da)
AU (1) AU652006B2 (da)
CA (1) CA2093816A1 (da)
DE (1) DE69110897T2 (da)
DK (1) DK0552280T3 (da)
ES (1) ES2073777T3 (da)
WO (1) WO1992006192A1 (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3351476B2 (ja) * 1993-01-22 2002-11-25 三菱化学株式会社 リン脂質誘導体及びそれを含有するリポソーム
WO1995016437A1 (en) * 1993-12-17 1995-06-22 Micro-Pak, Inc. Method of transmitting a biologically active material to a cell
DE69535758D1 (de) 1994-08-29 2008-07-03 Univ Wake Forest Lipid-analoge zur behandlung von viralen infektionen
US7135584B2 (en) 1995-08-07 2006-11-14 Wake Forest University Lipid analogs for treating viral infections
US6776986B1 (en) 1996-06-06 2004-08-17 Novartis Ag Inhibition of HIV-1 replication by antisense RNA expression
US7026469B2 (en) 2000-10-19 2006-04-11 Wake Forest University School Of Medicine Compositions and methods of double-targeting virus infections and cancer cells
US7309696B2 (en) 2000-10-19 2007-12-18 Wake Forest University Compositions and methods for targeting cancer cells
CN100469131C (zh) 2001-08-31 2009-03-11 汤姆森许可公司 实现条件存取系统和传输、接收及处理内容的方法和设备
JP2007505925A (ja) * 2003-09-17 2007-03-15 レット ゼア ビー ホープ メディカル リサーチ インスティチュート 骨髄性およびリンパ様免疫細胞への薬物の送達のための標的化脂質薬物製剤

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1327171C (en) * 1987-06-26 1994-02-22 Lisa J. Hock Recombinant human cytomegalovirus containing foreign gene and use thereof
DE3742049A1 (de) * 1987-12-11 1989-06-22 Theurer Karl Eugen Herstellung und anwendung von impfstoffen und diagnostika fuer virus- und krebserkrankungen
EP0402402B1 (en) * 1988-02-26 1995-12-27 Worcester Foundation For Biomedical Research, Inc. Inhibition of htlv-iii by exogenous oligonucleotides

Also Published As

Publication number Publication date
ATE124457T1 (de) 1995-07-15
DE69110897D1 (de) 1995-08-03
EP0552280B1 (en) 1995-06-28
AU652006B2 (en) 1994-08-11
EP0552280A1 (en) 1993-07-28
JPH06504429A (ja) 1994-05-26
CA2093816A1 (en) 1992-04-10
AU8875991A (en) 1992-04-28
WO1992006192A1 (en) 1992-04-16
DE69110897T2 (de) 1995-11-30
ES2073777T3 (es) 1995-08-16

Similar Documents

Publication Publication Date Title
DE69532369D1 (de) Rekombinantes infektiöses nicht-in-Segmente-geteiltes, negativ-Strange-RNS-Virus
DE69535125D1 (de) Impstoff gegen felines immunodefizienz-virus
FI903427A0 (fi) I vatten aoterdispergerbara polymerisatpulver, vilka aer framstaellda genom sprutning av polymerisatvattendispersioner, och anvaendning av dessa som tillsatsmedel foer hydrauliksa bindemedel.
DK0531370T3 (da) Inhibering af virusinfektion
DK0552280T3 (da) Inhibering af viral replikation
DE60126933D1 (de) Verfahren zur fermentativen herstellung von l-threonine
DE69429249D1 (de) Gegen plrv-infektion resistente pflanzen
DE69230535T2 (de) Polyphenol oxidase gene
AU2001279581A1 (en) Medicament comprising a dna sequence, which codes for the rna-binding koc protein, and comprising a koc protein or dna sequence of the koc promoter
ES2062990T3 (es) Vacunas, que contienen la proteina f del virus del sida.
DE60042922D1 (de) Virale expressionsvektoren für pflanzen
DE69534945D1 (de) Impfstoff für die infektiöse peritonitis der katzen
DE69733948D1 (de) In vivo herstellung von replicativen molekülen
NO20005482L (no) Rekombinant virus og anvendelser derav samt vaksine som omfatter nevnte virus.
AU2003281917A8 (en) Vaccine against infections caused by oncoviruses such as the feline leucosis virus of cats
WO1998042847A3 (de) Papillomvirus-hauptcapsid-proteins und deren verwendung in diagnose, therapie und vakzinierung
WO2002083896A3 (en) Recombinant segmented negative strand virus with a duplicated 3' noncoding flanking sequence, and therapeutic compositions containing the same
WO2004027066A3 (fr) Protéine recombinante chimérique et diagnostic in vitro du hiv
FI964784A (fi) Yhdistelmä-DNA-viruksia, valmistus ja käyttö geeniterapiassa
EE200100234A (et) PRV-1-geen ja selle kasutamine
ES2084587T3 (es) Arn virus no revertientes.
FI890231A (fi) Çkaerlekssigillç, aer ett çlaosç som laoses antingen med verktyg eller foer hand, men som inte kan upplaoses utan att den gaor soender.